Repare Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,073 | $52,404 |
Gross Profit | 585 | 51,903 | ||
EBITDA | -30,342 | -34,367 | -36,818 | 11,317 |
EBIT | -30,796 | -34,845 | -37,306 | 10,816 |
Net Income | -28,671 | -34,406 | -34,774 | 13,162 |
Net Change In Cash | 0 | 0 | 1,073 | 52,404 |
Free Cash Flow | -27,324 | -30,539 | -30,514 | 11,932 |
Cash | 84,717 | 80,541 | 79,820 | 103,217 |
Basic Shares | 424,526 | 42,452 | 42,445 | 44,024 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $53,477 | $51,133 | $131,830 | $7,600 |
Gross Profit | 53,477 | -80,070 | 127,646 | 4,256 |
EBITDA | -90,223 | -114,273 | -17,818 | -107,189 |
EBIT | -92,144 | -116,224 | -22,002 | -110,533 |
Net Income | -84,689 | -93,796 | -29,047 | -106,908 |
Net Change In Cash | 53,477 | 51,133 | 131,830 | 7,600 |
Cost of Revenue | 8,085 | |||
Free Cash Flow | -76,445 | -129,096 | -280 | -87,486 |
Cash | 84,717 | 111,268 | 159,521 | 334,427 |
Basic Shares | 42,411 | 42,093 | 41,922 | 37,818 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.67 |
2024-09-30 | -$0.77 |
2024-06-30 | -$0.82 |
2024-03-31 | $0.30 |
